According to a recently published report by Brisk Insights, the Global Actinic Keratosis Market is expected to grow at the CAGR of 3.9% during 2017-2025. The global actinic keratosis market is segmented on the basis of treatment and geography. The report on global actinic keratosis market (by treatment and geography) provides a detailed overview and predictive analysis of the market.
Full report available on Actinic Keratosis Market: Global Industry Size, Growth, Share and Forecast to 2025 report at http://www.briskinsights.com/report/actinic-keratosis-market
The key factor responsible for the development of actinic keratosis is advancing age with high occurrence rate in men as against women. In base year 2016, destructive treatment, especially cryosurgery of the treatment segment held the largest market share, because of its efficiency and cost effectiveness. Topical medication is very effective as a prolonged treatment regimen but lack of patient compliance hinders the growth of this segment. Photodynamic therapy consisting of 5-aminolevulinic acid (ALA), methyl aminolevulinate (MAL), will register faster growth due to the growing demand for non-invasive treatment and respective aesthetic appeal. The actinic keratosis market is currently dominated by North America due to increasing prevalence of actinic keratosis cases, favorable reimbursement scenario and developed healthcare infrastructure. Asia Pacific will be the fastest growing market due to growing public awareness and rapid development in the healthcare infrastructure.
Scope of the report
1. Global Actinic Keratosis Market, by Treatment, 2015–2025 ($ Millon)
1.1. Destructive Treatment
1.1.1. Liquid Nitrogen Cryotherapy
1.1.2. Surgical Therapy
1.2. Photodynamic Therapy
1.2.1. 5-Aminolevulinic acid (ALA)
1.2.2. Methyl aminolevulinate (MAL)
1.3. Topical medications
1.3.1. 5- Fluorouracil
1.3.4. Diclofenac Sodium
1.4. Chemical Peel and Others
2. Global Actinic Keratosis Market, by Geography, 2015-2025 ($ Millon)
2.1. North America
2.2.4. Rest of Europe
2.3. Asia Pacific
2.3.3. Rest of Asia Pacific
2.4. Latin America (LATAM)
2.4.3. Rest of Latin America
2.5. Middle East and Africa (MEA)
2.5.2. Rest of Middle East and Africa
3. Company Profiles
3.1. Apotex, Inc. LLC.
3.2. Aqua Pharmaceuticals, LLC
3.3. DUSA Pharmaceuticals, Inc. (Sun Pharma)
3.4. Galderma S.A.
3.5. LEO Laboratories Ltd.
3.6. Perrigo Company plc,
3.7. Tolmar Pharmaceuticals, Inc.
3.8. Valeant Pharmaceuticals International, Inc.
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.
109 Vernon House, Friar Lane, Nottingham, NG1 6DQ
Phone: +448081890034 (UK)